Preprint / Version 1

DNA methylation on PPARG and its relation to sports injury and pain in male football (soccer) players at all levels.




injury, Sports Medicine, genetics, epigenetics, football injuries, football, soccer, soccer injuries, Rehabilitation and Therapy, Physiotherapy


Injuries in English football are a cause of great financial burden to clubs and cause distress to players and coaching staff, therefore novel interventions to help prevent injuries should be considered to aid this burden. 287 male players across multiple levels of the English football leagues were tested using saliva for methylation levels across the gene PPARG, a known inflammation modulation gene. Player injury status and pain scale for each player was analysed at the point of testing to compare against the PPARG methylation status. The average methylation across PPARG on non-injured players was 0.508 and on those injured (n=78) was 0.4488, the difference between player/s indicating a pain score of 10 against the players indicating a pain score of 0 was +0.2437 towards the lower pain result. Therefore, it is theorised that PPARG hypomethylation occurs in response to injury or/and overtraining to aid in the inflammation processes of the body, this study will require further investigation to establish this link. Follow-up analysis on the same players that indicated injury and a high pain score to see if PPARG methylation returns to normative values upon physical improvement is also a logical step for further analysis.


Metrics Loading ...


Eliakim E, Morgulev E, Lidor R, et alEstimation of injury costs: financial damage of English Premier League teams’ underachievement due to injuriesBMJ Open Sport & Exercise Medicine 2020;6:e000675. doi: 10.1136/bmjsem-2019-000675

Bouhlel MA, et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6:137–143. doi: 10.1016/j.cmet.2007.06.010.

Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes & Development, 16(1), 6-21. doi: 10.1101/gad.947102

Jones, P. A., & Takai, D. (2001). The role of DNA methylation in mammalian epigenetics. Science, 293(5532), 1068-1070. doi: 10.1126/science.1063852

Suzuki, M. M., & Bird, A. (2008). DNA methylation landscapes: Provocative insights from epigenomics. Nature Reviews Genetics, 9(6), 465-476. doi: 10.1038/nrg2341

Wu, S. C., & Zhang, Y. (2011). Active DNA demethylation: Many roads lead to Rome. Nature Reviews Molecular Cell Biology, 11(9), 607-620. doi: 10.1038/nrm2950

Lakshminarasimhan R & Liang G. The Role of DNA Methylation in Cancer. Adv Exp Med Biol. 2016;945:151-172. doi: 10.1007/978-3-319-43624-1_7. PMID: 27826838; PMCID: PMC7409375.

Esteller, M. (2008). Epigenetics in cancer. New England Journal of Medicine, 358(11), 1148-1159. doi: 10.1056/NEJMra072067.

Counts JL, Goodman JI. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion. Prog Clin Biol Res. 1995;391:81-101. PMID: 8532739.

Crosby MB, Zhang J, Nowling TM, Svenson JL, Nicol CJ, Gonzalez FJ, Gilkeson GS. Inflammatory modulation of PPAR gamma expression and activity. Clin Immunol. 2006 Feb-Mar;118(2-3):276-83. doi: 10.1016/j.clim.2005.09.018. Epub 2005 Nov 21. PMID: 16303334.

Cai W, Yang T, Liu H, Han L, Zhang K, Hu X, Zhang X, Yin KJ, Gao Y, Bennett MVL, Leak RK, Chen J. Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair. Prog Neurobiol. 2018 Apr-May;163-164:27-58. doi: 10.1016/j.pneurobio.2017.10.002. Epub 2017 Oct 12. PMID: 29032144; PMCID: PMC6037317.

Verlinden, I., Güiza, F., Derese, I. et al. Time course of altered DNA methylation evoked by critical illness and by early administration of parenteral nutrition in the paediatric ICU. Clin Epigenet 12, 155 (2020).

Małodobra-Mazur M, Cierzniak A, Kaliszewski K, Dobosz T. PPARG Hypermethylation as the First Epigenetic Modification in Newly Onset Insulin Resistance in Human Adipocytes. Genes (Basel). 2021 Jun 9;12(6):889. doi: 10.3390/genes12060889. PMID: 34207541; PMCID: PMC8228025.

Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011 Oct;2(4):236-40. doi: 10.4103/2231-4040.90879. PMID: 22247890; PMCID: PMC3255347.

Kabiri S, Choi J, Shadmanfaat SMS, Lee J. Control Deficits, Conditioning Factors, and Playing through Pain and Injury among Iranian Professional Soccer Players. Int J Environ Res Public Health. 2021 Mar 25;18(7):3387. doi: 10.3390/ijerph18073387. PMID: 33805863; PMCID: PMC8036426.

Langie SAS, Moisse M, Declerck K, Koppen G, Godderis L, Vanden Berghe W, Drury S, De Boever P. Salivary DNA Methylation Profiling: Aspects to Consider for Biomarker Identification. Basic Clin Pharmacol Toxicol. 2017 Sep;121 Suppl 3(Suppl Suppl 3):93-101. doi: 10.1111/bcpt.12721. Epub 2017 Feb 10. PMID: 27901320; PMCID: PMC5644718.